BioSpace News Archive

Seagen Announces TUKYSA ® (tucatinib) in Combination with Trastuzumab Granted Priority Review by FDA for Previously Treated HER2-Positive Metastatic Colorectal Cancer.

enVVeno Medical Corporation today announced it will host a conference call and webcast on Wednesday, September 21, 2022 at 4:30 PM ET.

Longhorn Vaccines and Diagnostics LLC , a One Health and One World company developing vaccines and diagnostic tools for global public health and zoonosis concerns, today announced that Jerry Torrison, DVM, PhD, Senior Vice President of Animal Health, will present at the Allen D. Leman Swine Conference, being held in the St. Paul River Center, Minnesota, on Sept. 17 – 20, 2022.

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it plans to host its 9th annual series of “RNAi Roundtable” webinars over the coming weeks.

SeaStar Medical, and LMF Acquisition Opportunities, Inc. (NASDAQ: LMAO) (LMAO), today announced the appointment of Dr. Sai Prasad N. Iyer, Ph.D to the position of Vice President, Medical Affairs and Clinical Development at SeaStar Medical, effective September 15, 2022.

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it will present data demonstrating sustained improvements with long-term INGREZZA ® (valbenazine) capsules treatment in adults with tardive dyskinesia (TD) at the Psych Congress 2022 scientific meeting being held September 17-20.

Modern histopathology involves multiple methods to analyze human cells, including tissue scans and anamnesis data.

RenovoRx, Inc. today announced that Angela Gill Nelms has joined the company as Chief Operating Officer (“COO”).

Vistagen today announced that data highlighting intranasal administration of PH94B, the Company’s first-in-class synthetic investigational pherine nasal spray in Phase 3 development for acute treatment of social anxiety disorder, were presented at Psych Congress in New Orleans on September 18, 2022.

Neogen ® Corporation (NASDAQ: NEOG) announced today that it has released its innovative Veratox ® VIP assay for the detection of cashew, the second assay in Neogen’s new Veratox VIP line of enhanced quantitative ELISA products.